Zobrazeno 1 - 10
of 451
pro vyhledávání: '"R. Preiss"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Olivier Sitbon, Marius M. Hoeper, Gérald Simonneau, Kelly Chin, Lewis J. Rubin, Sean Gaine, Hossein Ardeschir Ghofrani, Richard N. Channick, R Preiss, Victor F. Tapson, Irene Lang, Rafael Sauter, Vallerie V. McLaughlin, Nazzareno Galiè
Publikováno v:
Chest. 160:277-286
Background Early initiation of pulmonary arterial hypertension (PAH) therapies is associated with improved long-term outcomes, yet data on the early use of prostacyclin pathway agents are limited. In these post hoc analyses of the Prostacyclin (PGI2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a30d0498a5c32c4355d979942def487
https://doi.org/10.1016/j.chest.2021.01.066
https://doi.org/10.1016/j.chest.2021.01.066
Autor:
Nazzareno Galiè, Lilla Di Scala, Marius M. Hoeper, Raymond L. Benza, Vallerie V. McLaughlin, Lewis J. Rubin, Olivier Sitbon, Sean Gaine, Richard N. Channick, Hossein Ardeschir Ghofrani, R Preiss, Gérald Simonneau, Victor F. Tapson, Irene M. Lang, Kelly Chin
Publikováno v:
The Journal of Heart and Lung Transplantation. 39:300-309
BACKGROUND: Approaches to risk assessment in pulmonary arterial hypertension (PAH) include the noninvasive French risk assessment approach (number of low-risk criteria based on the European Society of Cardiology and European Respiratory Society guide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0d12b1ffcd488ad47b6ead669d51440
https://doi.org/10.1016/j.healun.2019.12.013
https://doi.org/10.1016/j.healun.2019.12.013
Kniha
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Marius M. Hoeper, Sean Gaine, L Di Scala, Richard N. Channick, I. Lang, N Galie, O. Sitbon, R Preiss, Hossein Ardeschir Ghofrani, Lewis J. Rubin, Vallerie V. McLaughlin, G. Simonneau, Victor F. Tapson, K. Chin
Publikováno v:
61. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V..
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::857283ef96bbbd3742069b63d117c449
https://doi.org/10.1055/s-0039-3403194
https://doi.org/10.1055/s-0039-3403194
Autor:
Bartosz Jenner, Vallerie V. McLaughlin, G. Simonneau, I. Lang, Hossein Ardeschir Ghofrani, Stephan Rosenkranz, Marius M. Hoeper, N Galie, Lewis J. Rubin, O. Sitbon, R Preiss, Victor F. Tapson, Sean Gaine, Richard N. Channick, K. Chin
Publikováno v:
61. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V..
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47ea607d9d54da3183aa72a861e0853e
https://doi.org/10.1055/s-0039-3403192
https://doi.org/10.1055/s-0039-3403192
Autor:
Nazzareno Galiè, Ioana R. Preston, Marius M. Hoeper, Lilla Di Scala, Lewis J. Rubin, G. Simonneau, Vallerie V. McLaughlin, Sean Gaine, Harrison W. Farber, Olivier Sitbon, Kelly Chin, Richard N. Channick, R Preiss, Victor F. Tapson, Irene M. Lang, Hossein Ardeschir Ghofrani
Publikováno v:
The Journal of Heart and Lung Transplantation. 37:401-408
Background: Parenteral prostacyclin analogs that target the prostacyclin pathway have been used to treat pulmonary arterial hypertension (PAH) since the 1990s. Abrupt discontinuation of parenteral prostacyclin analogs can be associated with acute det
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be69c5078106dd42c98d2c92fd6e19d4
https://doi.org/10.1016/j.healun.2017.09.024
https://doi.org/10.1016/j.healun.2017.09.024
Autor:
Lewis J. Rubin, Marius M. Hoeper, R Preiss, Lilla Di Scala, Sean Gaine, J. Gerry Coghlan, Victor F. Tapson, Richard N. Channick, Irene M. Lang, Kelly Chin, Hossein Ardeschir Ghofrani, Olivier Sitbon, Gérald Simonneau, Vallerie V. McLaughlin, Nazzareno Galiè
Publikováno v:
American Journal of Cardiovascular Drugs
Background In pulmonary arterial hypertension (PAH), combination therapy is an important treatment strategy. Although randomized controlled trial data are available to support the combination of two therapies, data regarding triple combination therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::210280b1d2120a77eb7b400f5fc4eca4
https://doi.org/10.1007/s40256-017-0262-z
https://doi.org/10.1007/s40256-017-0262-z
Autor:
Bartosz Jenner, LJ Rubin, N Galie, Marius M. Hoeper, Tapson, I.M. Lang, Hossein Ardeschir Ghofrani, Stephan Rosenkranz, K. Chin, McLaughlin, G. Simonneau, O. Sitbon, R Preiss, Sean Gaine, Richard N. Channick
Publikováno v:
European Heart Journal. 40
Introduction Many PAH patients today have a number of CV comorbidities, yet data on the efficacy and safety of therapies in such patients remain scarce. Most recent PAH clinical trials also include patients with comorbidities. Purpose To assess the l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52468039d1163809c7d7ce92a5e753f7
https://doi.org/10.1093/eurheartj/ehz746.0032
https://doi.org/10.1093/eurheartj/ehz746.0032
Autor:
Marius M. Hoeper, Hossein Ardeschir Ghofrani, N Galie, LJ Rubin, L Di Scala, O. Sitbon, G. Simonneau, R Preiss, Sean Gaine, Richard N. Channick, I.M. Lang, Vallerie V. McLaughlin, Kelly Chin, Victor F. Tapson
Publikováno v:
A105. GLORY DAYS: THE LATEST CLINICAL RESEARCH IN PAH.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::602b543f2556f70318116d732adc69ca
https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2502
https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2502